SEC Filing Summary: National Health Investors Inc (NHI)
Business Context and Reporting Period
This Form 8-K was filed by National Health Investors Inc on November 6, 2025. The filing serves as a Regulation FD disclosure to furnish Supplemental Information for the quarter ended September 30, 2025. The company is incorporated in Maryland and trades on the New York Stock Exchange under the symbol NHI.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced Supplemental Information (Exhibit 99.1) available on the company's website, but are not detailed in the body of this 8-K report.
Material Changes
No material changes versus the prior comparable period are described in the text of this filing. The document acts solely as a notice of the availability of supplemental quarterly data.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. Investors are directed to the Supplemental Information for the quarter ended September 30, 2025, for further details.
Investor Verification Checklist
- Verify the specific financial metrics (revenue, FFO, debt levels) in the Supplemental Information (Exhibit 99.1) referenced in this filing.
- Confirm the availability of the supplemental report on the company's official website (www.nhireit.com).
- Review the full text of Exhibit 99.1 for any material updates to the company's outlook or risk profile not captured in this summary notice.